Member Press Releases

According to a recent Lancet report, Antimicrobial Resistance (AMR) isn’t a pandemic in waiting, its already here. AMR infections are estimated to cause 700,000 deaths each year globally. That figure is predicted to rise to 10 million, alongside a cumulative cost of $1 trillion, by 2050 if no action is taken. That’s a hundred times greater than the global economic threat of covid-19.

AMLo Biosciences Ltd (AMLo), an innovative medical device company spun out of Newcastle University specialising in the early detection of skin cancers, is pleased to announce it has secured significant further investment totalling £2.45m.

BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced that it has appointed Jennifer Murphy as Senior Vice President of Global Commercial Operations. In her new role, Jennifer will be responsible for building and growing the global commercial programs for all BioIVT’s product lines and services

The North East Innovation Lab, originally established as part of the region’s integrated Covid hub, has received an investment of £1.4 million to continue work on assessing and evaluating the next generation of diagnostic tests

Transaction expands BioIVT’s donor network and increases its capacity to provide fresh whole blood, plasma, serum, and red blood cells for drug and diagnostic development

RQM+, the world’s leading provider of regulatory, clinical and quality solutions to the MedTech industry, today announced the appointment of Margaret Keegan as CEO. Keegan succeeds co-founder Maria Fagan, who is retiring and will join the board of directors as vice chair.

FluoretiQ Limited the award-winning start-up, pioneering NANOPLEX a 15-minute proprietary diagnostic platform for bacterial infections today announced the completion of a £1.1 million, pre-series A investment

A North East-based lab is celebrating one year since it was set up to accelerate the development of the next generation of virus testing

A new product developed between Bedford-based Life Science Group Ltd (LSG) and Coventry University has the potential to transform the delivery of cell and gene therapy and in the longer term make these cutting-edge, personalised treatments more accessible

A new clinical validation study from Oulu University Hospital was recently published in a widespread international cancer journal, confirming that new-generation GastroPanel® test is highly accurate in diagnosing atrophic gastritis and Helicobacter pylori infection in gastroscopy referral patients